Valuation: Illumina, Inc.

Market Cap 36.02B 32.18B 29.56B 26.84B 50.41B 3,412B 51.68B 353B 142B 1,801B 135B 132B 5,708B P/E 2026 *
46.8x
P/E 2027 * 39.8x
Enterprise Value 35.93B 32.1B 29.49B 26.78B 50.29B 3,404B 51.56B 352B 142B 1,797B 135B 132B 5,694B EV / Sales 2026 *
7.76x
EV / Sales 2027 * 7.05x
Free-Float
74.99%
Yield 2026 *
-
Yield 2027 * -
1 day+5.13%
1 week-14.76%
Current month+0.94%
1 month-12.76%
3 months+20.21%
6 months+75.44%
Current year+81.62%
1 week 223.33
Extreme 223.33
293.17
1 month 223.33
Extreme 223.33
309.34
Current year 112.65
Extreme 112.65
309.34
1 year 112.65
Extreme 112.65
309.34
3 years 68.7
Extreme 68.7
309.34
5 years 68.7
Extreme 68.7
428
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer 55 28/05/2025
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
05/10/26 Tax

Chief Executive Officer

-1,303 0.0009%
30/09/26
Corvex Management LP
OtherCompany 0 0% -
30/09/26 Free

Director

113 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+5.13%-14.76%+98.52%+103.74% 36.02B
+2.30%+0.77%+23.63%+53.57% 259B
+0.94%-0.81%+7.50%+16.29% 162B
+0.89%-1.15%-19.01%+58.25% 153B
-1.85%-3.46%-55.88%-17.19% 63.04B
+2.39%+4.41%-9.71%-6.52% 54.01B
+2.07%+4.81%+14.59%+41.93% 54.87B
-1.23%-3.27%+3.58%+55.82% 49.09B
+2.02%-1.14%+21.27%+60.94% 49.47B
+2.31%-1.85%+33.08%+76.55% 45.18B
Average +2.34%-2.05%+11.76%+44.34% 92.51B
Weighted average by Cap. +2.10%-1.10%+8.05%+42.39%

Financials

2026 *2027 *
Net sales 4.63B 4.14B 3.8B 3.45B 6.48B 439B 6.65B 45.38B 18.25B 232B 17.39B 17.02B 734B 4.95B 4.42B 4.06B 3.69B 6.93B 469B 7.1B 48.51B 19.51B 248B 18.59B 18.19B 785B
Net income 798M 713M 655M 595M 1.12B 75.6B 1.15B 7.82B 3.14B 39.9B 3B 2.93B 126B 920M 822M 755M 686M 1.29B 87.15B 1.32B 9.01B 3.63B 46B 3.45B 3.38B 146B
Net Debt -83.57M -74.66M -68.58M -62.28M -117M -7.92B -120M -819M -329M -4.18B -314M -307M -13.24B -1.1B -985M -905M -822M -1.54B -104B -1.58B -10.8B -4.35B -55.14B -4.14B -4.05B -175B
Projected Income Statement - Annual - Illumina, Inc.
Logo Illumina, Inc.
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (85.4%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (14.6%). Net sales are distributed geographically as follows: the United States (51.6%), Americas (3.8%), Europe (29.1%), Asia/Pacific/Middle East/Africa (9.9%) and China/Taiwan/Hong Kong (5.6%).
Employees
8,625
Date Price Change Volume
03/11/26 US$238.21 +5.13% 2,232,175
02/11/26 US$226.58 -3.99% 2,925,989
30/10/26 US$235.99 -18.64% 5,390,386
29/10/26 US$290.06 +0.44% 2,035,238
28/10/26 US$288.79 +3.33% 2,239,437
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Illumina, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
238.21USD
Average target price
261.60USD
Spread / Average Target
+9.82%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Illumina, Inc.
  1. Stock Market
  2. Stocks
  3. ILMN Stock